Impax Asset Management Group plc Trims Stock Position in Ins

Impax Asset Management Group plc cut its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,451 shares of the medical instruments supplier’s stock after selling 216 shares during the period. […]

Related Keywords

Parkside , New York , United States , Manhattan , Shacey Petrovic , Robertw Baird , Piper Sandler , Stifel Nicolaus , Nasdaq , Bluepath Capital Management , Exchange Commission , Wolff Wiese Magana , Jpmorgan Chase Co , Parkside Financial Bank , Insulet Company Profile , Securities Exchange Commission , Insulet Corporation , Impax Asset Management Group , Barclays , Insulet Co , First Manhattan Co , Free Report , Asset Management Group , Financial Bank , Wiese Magana , Path Capital Management , First Manhattan , Get Free Report , Director Shacey Petrovic , Insulin Delivery System , Personal Diabetes Manager , Insulet Daily , Insulet , Nasdaq Podd , Podd , Medical , 45784p10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,